High Potency Handling
With over 30 years of experience in small molecule drug development, Quotient Sciences possesses the expertise to overcome the challenges that arise with HPAPIs.
First-in-Human to Proof-of-Concept
Our Translational Pharmaceutics approach enables First-in-Human studies by re-engineering the transition of your drug molecule into clinical development and shortening the timeline to Proof-of-Concept.
PPD & Quotient Pediatric Partnership
Through our partnership with PPD, we can provide one solution to execute an entire pediatric program with the potential for one contract and a single point of contact.
Inhaled Product Development
With more than 30 years’ experience, Quotient is a leader in the development, manufacture and assessment of inhalation products, helping clients to accelerate molecules from first-in-human through to proof-of-concept.
Formulation Development - Spray Drying
We use a broad range of formulation approaches to address complex solubility and bioavailability challenges, ensuring technology selection is driven by molecule need.
Clinical Trial Manufacturing
Understanding that early phase clinical testing is a pivotal milestone in the development of your drug product, Quotient Sciences offers clinical trial manufacturing, testing and certification services designed to meet your individual requirements.
We offer commercial manufacturing of small molecule products including niche therapies like oncology, orphan and pediatric indications.